E2F transcription factor 1/small nucleolar RNA host gene 18/microRNA-338-5p/forkhead box D1: an important regulatory axis in glioma progression

References

• Mazor G, Levin L, Picard D, et al. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells. Cell Death Dis. 2019;10:246.
   PubMed Web of Science ®Google Scholar
• Li Q, Dong C, Cui J, et al. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. J Exp Clin Cancer Res. 2018;37:265.
   PubMed Web of Science ®Google Scholar
• Li W, Wang L, Ji X-B, et al. MiR-199a inhibits tumor growth and attenuates chemoresistance by targeting K-RAS via AKT and ERK signalings. Front Oncol. 2019;9:1071.
   PubMed Web of Science ®Google Scholar
• Malouff TD, Peterson JL, Mahajan A, et al. Carbon ion radiotherapy in the treatment of gliomas: a review. J Neurooncol. 2019;145:191–199.
   PubMed Web of Science ®Google Scholar
• Han N, Yang L, Zhang X, et al. LncRNA MATN1-AS1 prevents glioblastoma cell from proliferation and invasion via RELA regulation and MAPK signaling pathway. Ann Transl Med. 2019;7:784.
   PubMed Web of Science ®Google Scholar
• Botti G, Scognamiglio G, Aquino G, et al. LncRNA in tumor microenvironment: what role? Int J Mol Sci. 2019;20(9):2279.
   Web of Science ®Google Scholar
• Uroda T, Anastasakou E, Rossi A, et al. Conserved pseudoknots in lncRNA MEG3 are essential for stimulation of the p53 pathway. Mol Cell. 2019;75(5):982–995.e9.
   PubMed Web of Science ®Google Scholar
• Pan Y-B, Wang S, Yang B, et al. Transcriptome analyses reveal molecular mechanisms underlying phenotypic differences among transcriptional subtypes of glioblastoma. J Cell Mol Med. 2020;24:3901–3916.
   PubMed Web of Science ®Google Scholar
• Zeng J, Li Y, Wang Y, et al. lncRNA 00312 attenuates cell proliferation and invasion and promotes apoptosis in renal cell carcinoma via miR-34a-5p/ASS1 axis. Oxid Med Cell Longev. 2020;2020:5737289.
   PubMed Web of Science ®Google Scholar
• Ye F, Xu R, Ge Y, et al. LINC00963 confers oncogenic properties in glioma by regulating the miR-506/BCAT1 axis. Cancer Manag Res. 2020;12:2339–2351.
   PubMed Web of Science ®Google Scholar
• Luo L, Zhang Y, He H, et al. LncRNA FEZF1-AS1 sponges miR-34a to upregulate Notch-1 in glioblastoma. Cancer Manag Res. 2020;12:1827–1833.
   PubMed Web of Science ®Google Scholar
• Zheng R, Yao Q, Ren C, et al. Upregulation of long noncoding RNA small nucleolar RNA host gene 18 promotes radioresistance of glioma by repressing semaphorin 5A. Int J Radiat Oncol Biol Phys. 2016;96:877–887.
   PubMed Web of Science ®Google Scholar
• Zheng R, Yao Q, Li X, et al. Long noncoding ribonucleic acid promotes glioma cell motility disruption of α-enolase nucleocytoplasmic transport. Front Genet. 2019;10:1140.
   PubMed Web of Science ®Google Scholar
• Kim EY, Alvarez-Baron CP, Dryer SE. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes. Mol Pharmacol. 2009;75:466–477.
   PubMed Web of Science ®Google Scholar
• Yu H-R, Hsu T-Y, Huang H-C, et al. Comparison of the functional microRNA expression in immune cell subsets of neonates and adults. Front Immunol. 2016;7:615.
   PubMed Web of Science ®Google Scholar
• Liu P, Yang H, Zhang J, et al. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7:5186.
   PubMed Web of Science ®Google Scholar
• Beaulieu LM, Church FC. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Exp Cell Res. 2007;313:677–687.
   PubMed Web of Science ®Google Scholar
• Gu Z, Wu S, Wang J, et al. Long non-coding RNA LINC01419 mediates miR-519a-3p/PDRG1 axis to promote cell progression in osteosarcoma. Cancer Cell Int. 2020;20:147.
   PubMed Web of Science ®Google Scholar
• Kondo H, Ratcliffe CDH, Hooper S, et al. Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms. Cell Rep. 2021;34:108750.
   PubMed Web of Science ®Google Scholar
• Li P, Ge D, Li P, et al. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway. J Cell Mol Med. 2020;24:10151–10165.
   PubMed Web of Science ®Google Scholar
• Qian C, Chen S, Li S, et al. Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis. Oncol Rep. 2021;45. DOI:10.3892/or.2021.7996
   Web of Science ®Google Scholar
• Liao H, Liang Y, Kang L, et al. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2. Oncol Rep. 2021;45. DOI:10.3892/or.2021.8018
   Web of Science ®Google Scholar
• Joshi JB, Patel D, Morton DJ, et al. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Mol Oncol. 2017;11:337–357.
   PubMed Web of Science ®Google Scholar
• Colucci P, Marchetta E, Mancini GF, et al. Predicting susceptibility and resilience in an animal model of post-traumatic stress disorder (PTSD). Transl Psychiatry. 2020;10:243.
   PubMed Web of Science ®Google Scholar
• Hu W, Wang Z, Zhang S, et al. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling. Sci Rep. 2019;9:7539.
   PubMed Web of Science ®Google Scholar
• Tao C, Luo H, Chen L, et al. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma. Bioengineered. 2021;12:4016–4031.
   PubMed Web of Science ®Google Scholar
• Du X, Tu Y, Liu S, et al. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop. J Cell Mol Med. 2020;24:1474–1487.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang L, Liang Z, et al. RNA BCAR4 promotes growth, invasion and tumorigenicity by targeting miR-2276 to upregulate MMP7 expression in glioma. Onco Targets Ther. 2019;12:10963–10973.
   PubMed Web of Science ®Google Scholar
• Huang L-J, Shen Y, Bai J, et al. High expression levels of long noncoding RNA small nucleolar RNA host gene 18 and semaphorin 5A indicate poor prognosis in multiple myeloma. Acta Haematol. 2020;143:279–288.
   PubMed Web of Science ®Google Scholar
• Liu X-F, Thin KZ, Ming X-L, et al. Small nucleolar RNA host gene 18 acts as a tumor suppressor and a diagnostic indicator in hepatocellular carcinoma. Technol Cancer Res Treat. 2018;17:1533033818794494.
   Web of Science ®Google Scholar
• Qian Y, Wu X, Wang H, et al. MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin. Braz J Med Biol Res = Rev Bras Pesqui Med Biol. 2020;53:e9330.
   PubMed Web of Science ®Google Scholar
• Wu H, Li Y, Wang X, et al. Long non-coding RNA TUG1 knockdown prevents neurons from death to alleviate acute spinal cord injury via the microRNA-338/BIK axis. Bioengineered. 2021;12:5566–5582.
   PubMed Web of Science ®Google Scholar
• Wang W-Y, Lu W-C. Reduced expression of hsa-miR-338-3p contributes to the development of glioma cells by targeting mitochondrial 3-Oxoacyl-ACP Synthase (OXSM) in Glioblastoma (GBM). Onco Targets Ther. 2020;13:9513–9523.
   PubMed Web of Science ®Google Scholar
• Chu C-A, Lee C-T, Lee J-C, et al. MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway. EBioMedicine. 2019;43:270–281.
   PubMed Web of Science ®Google Scholar
• Liu D-Z, Zhao H, Zou Q-G, et al. MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma. Cancer Biomarkers. 2017;20:289–297.
   PubMed Web of Science ®Google Scholar
• Li C-H, Chang Y-C, Hsiao M, et al. FOXD1 and Gal-3 form a positive regulatory loop to regulate lung cancer aggressiveness. Cancers (Basel). 2019;11(12):1897.
   Web of Science ®Google Scholar
• Quintero-Ronderos P, Laissue P. The multisystemic functions of FOXD1 in development and disease. J Mol Med (Berl). 2018;96:725–739.
   PubMed Web of Science ®Google Scholar
• Li X, Jiao M, Hu J, et al. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4. Prostate. 2020;80:674–686.
   PubMed Web of Science ®Google Scholar
• Chang S, Sun L, Feng G. SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1. Biomed Pharmacothe. 2019;117:109133.
   PubMed Web of Science ®Google Scholar
• Chen C, Xu Z-Q, Zong Y-P, et al. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer. Cell Death Dis. 2019;10:178.
   PubMed Web of Science ®Google Scholar
• Pan F, Li M, Chen W. FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway. Am J Transl Res. 2018;10:1522–1530.
   PubMed Web of Science ®Google Scholar
• Gao Y-F, Zhu T, Mao X-Y, et al. Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells. Oncol Rep. 2017;37:1196–1202.
   PubMed Web of Science ®Google Scholar
• Ma X-L, Shang F, Ni W, et al. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1. J Cancer Res Clin Oncol. 2018;144:2351–2366.
   PubMed Web of Science ®Google Scholar
• Donaires FS, Godoy PRDV, Leandro GS, et al. E2F transcription factors associated with up-regulated genes in glioblastoma. Cancer Biomarkers. 2017;18:199–208.
   PubMed Web of Science ®Google Scholar
• Wang R, Li X, Sun C, et al. The ATPase Pontin is a key cell cycle regulator by amplifying E2F1 transcription response in glioma. Cell Death Dis. 2021;12:141.
   PubMed Web of Science ®Google Scholar
• Xu L, Chen Y, Mayakonda A, et al. Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma. Proc Natl Acad Sci U S A. 2018;115:E5086–E5095.
   PubMed Web of Science ®Google Scholar